1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117
Email jamie-miller@ouhsc.edu
Publications & Presentations
- 91. Chandler C, Miller J L, Cunnyngham C, Johnson P N. Propylene-glycol induced lactic acidosis in a child receiving a pentobarbital continuous infusion. Journal of Pediatric Intensive Care. 2014; 3 : 73-77
92. Lammers E M, Johnson P N, Ernst K D, Hagemann T M, Lawrence S M, Williams P K, Anderson M P, Miller J L. Association of fentanyl with neurodevelopmental outcomes in very-low-birth-weight infants. The Annals of pharmacotherapy. 2014; 48 : 335-42
93. Lammers E M, Johnson P N, Ernst K D, Hagemann T M, Lawrence S M, Williams P K, Anderson M, Miller J L. Association of fentanyl with neurodevelopmental outcomes in very-low-birth-weight infants. The Annals of pharmacotherapy. 2014; 48 : 335-42
94. Johnson P N, Miller J L, Hagemann T M, Castro C, Harrison D. External validation of the medication taper complexity score for methadone tapers in children with opioid abstinence syndrome. The Annals of pharmacotherapy. 2014; 48 : 187-95
95. Miller J L, Schaefer J, Tam M, Johnson P N. Ethacrynic acid continuous infusions in critically-ill pediatric patients. Journal of Pediatric Pharmacology and Therapeutics. 2014; 18 : 167
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 6. Pediatric Pharmacy Advocacy Group. Outstanding Original Research Award. Date: 2018.
7. Pediatric Pharmacy Advocacy Group. Scholarship in Teaching Award. Date: 2018.
8. Pediatric Pharmacy Advocacy Group. Christensen Memorial Young Investigator Award (Resident Mentor). Date: 2016.
9. Pediatric Pharmacy Advocacy Group. Outstanding Original Paper. Date: 2014.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.